Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

p21: structure and functions associated with cyclin-CDK binding

K L Ball1

  • 1Department of Biochemistry, Medical Sciences Institute, University of Dundee, UK.

Progress in Cell Cycle Research
|January 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Growth hormone deficiency in Sturge-Weber syndrome.

Archives of disease in childhood·2006
Same author

Differential post-translational modification of the tumour suppressor proteins Rb and p53 modulate the rates of radiation-induced apoptosis in vivo.

Oncogene·2001
Same author

Reversible phosphorylation at the C-terminal regulatory domain of p21(Waf1/Cip1) modulates proliferating cell nuclear antigen binding.

The Journal of biological chemistry·2001
Same author

v-Abl protein-tyrosine kinase up-regulates p21WAF-1 in cell cycle arrested and proliferating myeloid cells.

The Journal of biological chemistry·2000
Same author

Strategies for manipulating the p53 pathway in the treatment of human cancer.

The Biochemical journal·2000
Same author

Characterization of the cyclin-dependent kinase inhibitory domain of the INK4 family as a model for a synthetic tumour suppressor molecule.

Oncogene·1998
Same journal

Cytometry of cell cycle regulatory proteins.

Progress in cell cycle research·2003
Same journal

Selective protection of normal proliferating cells against the toxic effects of chemotherapeutic agents.

Progress in cell cycle research·2003
Same journal

The actin cytoskeleton as a therapeutic target: state of the art and future directions.

Progress in cell cycle research·2003
Same journal

Roles and regulation of serine/threonine-specific protein phosphatases in the cell cycle.

Progress in cell cycle research·2003
Same journal

The interaction of glycogen synthase kinase-3 (GSK-3) with the cell cycle.

Progress in cell cycle research·2003
Same journal

The peptidyl-prolyl isomerase Pin1.

Progress in cell cycle research·2003
See all related articles

The cyclin-dependent kinase inhibitor p21 is crucial for cellular response to damage. It regulates cell growth by interacting with key proteins, especially cyclin-dependent kinases.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • p21 is a key inhibitor of cyclin-dependent kinases.
  • It plays a critical role in cellular responses to negative growth signals and DNA damage.
  • p21 is regulated transcriptionally by the p53 tumor suppressor protein.

Purpose of the Study:

  • To highlight the multifunctional nature of p21.
  • To emphasize its role in coordinating cellular responses to growth inhibition.
  • To underscore the importance of its interaction with cyclin-dependent kinases.

Main Methods:

  • Literature review on p21 functions.
  • Analysis of p21's interactions with cellular proteins.
  • Examination of p21's role in cell cycle regulation.

Related Experiment Videos

Main Results:

  • p21 acts as a multifunctional protein.
  • It interfaces with various proteins involved in growth control.
  • Regulation of cyclin-dependent protein kinases is a primary function of p21.

Conclusions:

  • p21 is central to cellular growth control mechanisms.
  • Its ability to modulate cyclin-dependent kinase activity is essential for its diverse functions.
  • p21 integrates signals for cell cycle arrest and DNA repair.